Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis
Current inhibitors of platelet integrin αIIbβ3 cause excessive bleeding, which limited their clinical use in cardiac patients. Here the authors design pure orthosteric αIIbβ3 inhibitors that prevent platelet aggregation and thrombosis without causing bleeding in humanized mouse models of thrombosis...
Guardado en:
Autores principales: | Brian D. Adair, José L. Alonso, Johannes van Agthoven, Vincent Hayes, Hyun Sook Ahn, I-Shing Yu, Shu-Wha Lin, Jian-Ping Xiong, Mortimer Poncz, M. Amin Arnaout |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/42565adb3ba2424890108c840e099336 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Seminars in thrombosis and hemostasis
-
Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis
por: Xiaohong Ruby Xu, et al.
Publicado: (2018) -
Prophylactic orthosteric inhibition of leukocyte integrin CD11b/CD18 prevents long-term fibrotic kidney failure in cynomolgus monkeys
por: Abbas Dehnadi, et al.
Publicado: (2017) -
DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score.
por: Offer Erez, et al.
Publicado: (2014) -
Orthosteric- versus allosteric-dependent activation of the GABAA receptor requires numerically distinct subunit level rearrangements
por: Jahanshah Amin, et al.
Publicado: (2017)